Ascent Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,618
Closed -$823K 511
2023
Q4
$823K Buy
3,618
+116
+3% +$24.4K 0.08% 280
2023
Q3
$715K Buy
3,502
+2,227
+175% +$470K 0.08% 271
2023
Q2
$234K Sell
1,275
-254
-17% -$49.3K 0.03% 413
2023
Q1
$301K Sell
1,529
-109
-7% -$22.4K 0.03% 401
2022
Q4
$331K Sell
1,638
-556
-25% -$109K 0.04% 375
2022
Q3
$418K Sell
2,194
-1,094
-33% -$224K 0.05% 321
2022
Q2
$741K Sell
3,288
-1,504
-31% -$321K 0.09% 247
2022
Q1
$1.08M Buy
4,792
+224
+5% +$52.7K 0.13% 215
2021
Q4
$1.07M Buy
+4,568
New +$1.13M 0.14% 209

Other funds holding LH

Ascent Group's LH Position: Q1 2024 in Review

Ascent Group sold out of Labcorp (LH) in Q1 2024, closing a stake of 3,618 shares — an estimated $823K sold.

Ascent Group first reported a position in LH in Q4 2021 and held it in 9 quarters. The position peaked at $1.08M in Q1 2022. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Ascent Group reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Ascent Group sold 3,618 Labcorp shares in Q1 2024, an estimated $823K.
  • Ascent Group first reported a position in Labcorp in Q4 2021 and held it in 9 quarters.
  • Ascent Group's Labcorp position peaked at $1.08M in Q1 2022.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Ascent Group's 13F filing for Q1 2024, filed 15 May 2024.